Welcome to CDC stacks | Mycobacterium bovis Isolates with M. tuberculosis Specific Characteristics - 15856 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Mycobacterium bovis Isolates with M. tuberculosis Specific Characteristics
  • Published Date:
    May 2006
  • Source:
    Emerg Infect Dis. 12(5):763-765.
Filetype[PDF-92.25 KB]


Details:
No Related Documents.
You May Also Like:
  1. Mycobacterial Lineages Causing Pulmonary and Extrapulmonary Tuberculosis, Ethiopia
    Personal Author:
    Firdessa, Rebuma; Berg, Stefan; Hailu, Elena; Schelling, Esther; Gumi, Balako; Erenso, Girume; Gadisa, Endalamaw; Kiros, Teklu; Habtamu, Meseret; Hussein, Jemal; Zinsstag, Jakob; Robertson, Brian D.; Ameni, Gobena; Lohan, Amanda J.; Loftus, Brendan; Comas, Iñaki; Gagneux, Sebastien; Tschopp, Rea; Yamuah, Lawrence; Hewinson, Glyn; Gordon, Stephen V.; Young, Douglas B.; Aseffa, Abraham;
    Published:
    Mar 2013
    Source:
    Emerg Infect Dis. 19(3):460-463.
    Description:
    Molecular typing of 964 specimens from patients in Ethiopia with lymph node or pulmonary tuberculosis showed a similar distribution of Mycobacterium tuberculosis strains between the 2 disease manifestations and a minimal role for M. bovis. We report ...
    File Type:
    Filetype[PDF - 466.66 KB]
  2. Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis
    Personal Author:
    Scott, Colleen; Cavanaugh, Joseph S.; Silk, Benjamin J.; Ershova, Julia; Mazurek, Gerald H.; LoBue, Philip A.; Moonan, Patrick K.;
    Published:
    Mar 2017
    Source:
    Emerg Infect Dis. 23(3):456-462.
    Description:
    Current US guidelines recommend longer treatment for tuberculosis (TB) caused by pyrazinamide-resistant organisms (e.g., Mycobacterium bovis) than for M. tuberculosis TB. We compared treatment response times for patients with M. bovis TB and M. tuber...
    File Type:
    Filetype[PDF - 1.02 MB]
  3. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009
    Personal Author:
    Kurbatova, Ekaterina V.; Cavanaugh, Joseph S.; Dalton, Tracy; Click, Eleanor; Cegielski, J. Peter;
    Published:
    Jul 09 2013
    Source:
    Clin Infect Dis. 57(8):1081-1093.
    Description:
    Introduction : Pyrazinamide (PZA) is essential in tuberculosis (TB) treatment. We describe the prevalence, trends and predictors of PZA resistance in Mycobacterium tuberculosis complex (MTBC) in the U.S. : Methods : We analyzed culture-positive MTBC ...
    File Type:
    Filetype[PDF - 971.83 KB]
  4. Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis
    Personal Author:
    Baker, Lucy; Brown, Tim; Maiden, Martin C.; Drobniewski, Francis;
    Published:
    Sep 2004
    Source:
    Emerg Infect Dis. 10(9):1568-1577.
    Description:
    Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million people annually. Using a population-based approach that analyzes multiple loci around the chromosome, we demonstrate that neutral gene...
    File Type:
    Filetype[PDF - 309.04 KB]
  5. Pulmonary Tuberculosis due to Mycobacterium bovis in Captive Siberian Tiger
    Personal Author:
    Lantos, Ákos; Niemann, Stefan; Mezősi, László; Sós, Endre; Erdélyi, Károly; Dávid, Sándor; Parsons, Linda M.; Kubica, Tanja; Rüsch-Gerdes, Sabine; Somoskövi, Ákos;
    Published:
    Nov 2003
    Source:
    Emerg Infect Dis. 9(11):1462-1464.
    Description:
    We report the first case of pulmonary tuberculosis caused by Mycobacterium bovis subsp. caprae in a captive Siberian tiger, an endangered feline. The pathogen was isolated from a tracheal aspirate obtained by bronchoscopy. This procedure provided a r...
    File Type:
    Filetype[PDF - 211.83 KB]